Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 20, 2021 McDONALD’S CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware   1-5231   36-2361282 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.) 110 North Carpenter Street Chicago , Illinois (Address of Principal Executive Offices) 60607 (Zip Code) ( 630 ) 623-3000 (Registrant’s telephone number, including area code)   Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value MCD New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ Item 5.07. Submission of Matters to a Vote of Security Holders.     The following is a brief description and the voting results of each proposal voted upon at the Annual Shareholders’ Meeting held on May 20, 2021 of McDonald’s Corporation (the “Company”).     Each of the twelve Directors proposed by the Company were re-elected for a one-year term beginning in May and continuing until the Company’s 2022 Annual Shareholders’ Meeting and until their successors have been elected and qualified. The votes on this proposal were as follows: Director Name    For    Against    Abstain    Broker Non-Votes Lloyd Dean 479,411,242 20,283,555 884,844 104,585,676 Robert Eckert 438,925,416 60,730,521 923,704 104,585,676 Catherine Engelbert 497,573,708 2,213,615 792,318 104,585,676 Margaret Georgiadis 497,617,823 2,112,848 848,970 104,585,676 Enrique Hernandez, Jr. 350,725,528 148,927,252 926,861 104,585,676 Christopher Kempczinski 490,966,120 8,721,632 891,889 104,585,676 Richard Lenny 397,145,054 102,496,941 937,646 104,585,676 John Mulligan 495,615,097 4,026,665 937,879 104,585,676 Sheila Penrose 476,623,513 23,097,162 858,966 104,585,676 John Rogers, Jr. 461,685,686 37,999,108 894,847 104,585,676 Paul Walsh 454,817,289 44,784,659 977,693 104,585,676 Miles White 412,011,127 87,646,609 921,905 104,585,676     The proposal regarding an advisory vote to approve the compensation awarded to the Company’s named executive officers for 2020 was approved. The votes on this proposal were as follows: For    Against    Abstain   Broker Non-Votes 466,532,516 30,771,468 3,275,657 104,585,676 The proposal regarding an advisory vote to ratify the appointment of Ernst & Young LLP to serve as independent auditor for 2021 was approved. The votes on this proposal were as follows (there were no broker non-votes on this proposal): For    Against    Abstain   578,661,134 25,376,702 1,127,481     The proposal regarding an advisory vote on a shareholder proposal requesting a report on sugar and public health was not approved. The votes on this proposal were as follows: For    Against    Abstain   Broker Non-Votes 52,846,129 438,917,378 8,816,134 104,585,676 The proposal regarding an advisory vote on a shareholder proposal requesting a report on antibiotics and public health costs was not approved. The votes on this proposal were as follows: For    Against    Abstain   Broker Non-Votes 56,454,152 416,462,524 27,662,965 104,585,676     The proposal regarding an advisory vote on a shareholder proposal requesting the ability for shareholders to act by written consent was not approved. The votes on this proposal were as follows: For    Against    Abstain   Broker Non-Votes 212,252,064 285,447,888 2,879,689 104,585,676 SIGNATURES      Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.   McDONALD’S CORPORATION   (Registrant) Date: May 26, 2021 By: /s/ Denise A. Horne   Denise A. Horne   Corporate Vice President, Associate General Counsel and Assistant Secretary